1. 260 Low incidence of both new-onset and flares of uveitis in secukinumab-treated patients with ankylosing spondylitis: clinical trial and post-marketing safety analysis. (12th April 2019) Authors: Marzo-Ortega, Helena; Deodhar, Atul; Miceli-Richard, Corinne; Baraliakos, Xenofon; Gladman, Dafna D; Martin, Ruvie; Safi, Jorge; Porter, Brian; Shete, Abhijit Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period. (12th April 2019) Authors: McInnes, Iain B; Deodhar, Atul; Gladman, Dafna D; Ren, Mengyuan; Spindeldreher, Sebastian; Pricop, Luminita; Porter, Brian; Safi, Jorge; Shete, Abhijit; Bruin, Gerard Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies. (20th April 2020) Authors: Barkham, Nick; Schett, Georg; Baraliakos, Xenofon; van den Bosch, Filip; Deodhar, Atul; Gensler, Lianne S; Ǿstergaard, Mikkel; Agawane, Shital; Gupta, Ayan Das; Mpofu, Shephard; Fox, Todd; Winseck, Adam; Shete, Abhijit; Porter, Brian Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0380 SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES. (June 2019) Authors: Schett, Georg; Baraliakos, Xenofon; Bosch, Filip van den; Deodhar, Atul; Gensler, Lianne S.; Ǿstergaard, Mikkel; Agawane, Shital; Gupta, Ayan Das; Mpofu, Shephard; Fox, Todd; Winseck, Adam; Shete, Abhijit; Porter, Brian Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0388 SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM. (June 2019) Authors: Deodhar, Atul; Boonen, Annelies; Ferraccioli, Gianfranco; Bosch, Filip van den; Martinez, David; Porter, Brian; Shete, Abhijit; Gilloteau, Isabelle; Yocolly, Aurore; Strand, Vibeke Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0401 EFFECT OF LONG-TERM TREATMENT WITH SECUKINUMAB ON LIPID PROFILE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: POOLED 4 YEAR ANALYSIS. (June 2019) Authors: McInnes, Iain; Gladman, Dafna D.; Deodhar, Atul; Richard, Corinne Miceli; Nash, Peter; Shete, Abhijit; Asquith, Daren; Richards, Hanno; Pricop, Luminita; Wang, Jianyuan Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies. Issue 5 (30th April 2020) Authors: Deodhar, Atul A.; Miceli‐Richard, Corine; Baraliakos, Xenofon; Marzo‐Ortega, Helena; Gladman, Dafna D.; Blanco, Ricardo; Das Gupta, Ayan; Martin, Ruvie; Safi, Jorge; Porter, Brian; Shete, Abhijit; Rosenbaum, James T. Journal: ACR open rheumatology Issue: Volume 2:Issue 5(2020) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia. (2nd September 2018) Authors: Chawla, Manoj; Kim, Tae Ho; Mirasol, Roberto C.; Faruque, Pathan; Cooke, Kathryn; Hours-Zesiger, Peggy; Shete, Abhijit Journal: Current medical research and opinion Issue: Volume 34:Number 9(2018) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P190 Secukinumab improves back pain, morning stiffness, fatigue and physical function in tumour necrosis factor inhibitor-naive patients with non-radiographic axial spondyloarthritis: results from a randomised controlled Phase 3 study. (26th April 2021) Authors: Marzo-Ortega, Helena; Deodhar, Atul; Blanco, Ricardo Alonso; Kameda, Hideto; Kivitz, Alan; Poddubnyy, Denis; Magrey, Marina N; Wang, Jianyuan; Haemmerle, Sibylle; Shete, Abhijit; Braun, Jürgen Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P191 Secukinumab demonstrates a consistent safety profile in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis over long term: updated pooled safety analyses. (26th April 2021) Authors: McInnes, Iain B; Baraliakos, Xenofon; Deodhar, Atul; Gottlieb, Alice B; Lebwohl, Mark; Schreiber, Stefan; Marfo, Kwaku; Bao, Weibin; Richards, Hanno B; Pricop, Luminita; Shete, Abhijit; Safi, Jorge; Mease, Philip J Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗